nodes	percent_of_prediction	percent_of_DWPC	metapath
Timolol—ADRB3—polycystic ovary syndrome	0.608	0.724	CbGaD
Timolol—ADRB2—polycystic ovary syndrome	0.231	0.275	CbGaD
Timolol—Bupranolol—ADRB3—polycystic ovary syndrome	0.00252	0.444	CrCbGaD
Timolol—Respiratory distress—Metformin—polycystic ovary syndrome	0.00186	0.0594	CcSEcCtD
Timolol—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.00146	0.0466	CcSEcCtD
Timolol—Levobunolol—ADRB2—polycystic ovary syndrome	0.00132	0.233	CrCbGaD
Timolol—CYP2C19—urine—polycystic ovary syndrome	0.000959	0.212	CbGeAlD
Timolol—Bupranolol—ADRB2—polycystic ovary syndrome	0.000957	0.169	CrCbGaD
Timolol—Nasal congestion—Metformin—polycystic ovary syndrome	0.00094	0.0301	CcSEcCtD
Timolol—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.000877	0.0281	CcSEcCtD
Timolol—Penbutolol—ADRB2—polycystic ovary syndrome	0.000875	0.154	CrCbGaD
Timolol—Pain in extremity—Metformin—polycystic ovary syndrome	0.000856	0.0274	CcSEcCtD
Timolol—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00079	0.0253	CcSEcCtD
Timolol—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.000782	0.025	CcSEcCtD
Timolol—Breast disorder—Metformin—polycystic ovary syndrome	0.000774	0.0248	CcSEcCtD
Timolol—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.000765	0.0245	CcSEcCtD
Timolol—Angina pectoris—Metformin—polycystic ovary syndrome	0.000721	0.0231	CcSEcCtD
Timolol—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.000688	0.022	CcSEcCtD
Timolol—ADRB3—adipose tissue—polycystic ovary syndrome	0.000625	0.138	CbGeAlD
Timolol—Bradycardia—Metformin—polycystic ovary syndrome	0.000603	0.0193	CcSEcCtD
Timolol—Rhinitis—Metformin—polycystic ovary syndrome	0.000594	0.019	CcSEcCtD
Timolol—Oedema peripheral—Metformin—polycystic ovary syndrome	0.000583	0.0187	CcSEcCtD
Timolol—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.000582	0.0186	CcSEcCtD
Timolol—CYP2D6—urine—polycystic ovary syndrome	0.000558	0.124	CbGeAlD
Timolol—Eye disorder—Metformin—polycystic ovary syndrome	0.000553	0.0177	CcSEcCtD
Timolol—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00055	0.0176	CcSEcCtD
Timolol—Angiopathy—Metformin—polycystic ovary syndrome	0.000537	0.0172	CcSEcCtD
Timolol—Immune system disorder—Metformin—polycystic ovary syndrome	0.000535	0.0171	CcSEcCtD
Timolol—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000534	0.0171	CcSEcCtD
Timolol—ADRB3—female gonad—polycystic ovary syndrome	0.000523	0.116	CbGeAlD
Timolol—Erythema—Metformin—polycystic ovary syndrome	0.000516	0.0165	CcSEcCtD
Timolol—Malnutrition—Metformin—polycystic ovary syndrome	0.000516	0.0165	CcSEcCtD
Timolol—Dysgeusia—Metformin—polycystic ovary syndrome	0.000505	0.0162	CcSEcCtD
Timolol—Vision blurred—Metformin—polycystic ovary syndrome	0.000486	0.0156	CcSEcCtD
Timolol—Syncope—Metformin—polycystic ovary syndrome	0.000462	0.0148	CcSEcCtD
Timolol—Palpitations—Metformin—polycystic ovary syndrome	0.000456	0.0146	CcSEcCtD
Timolol—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000453	0.0145	CcSEcCtD
Timolol—Hypertension—Metformin—polycystic ovary syndrome	0.000445	0.0142	CcSEcCtD
Timolol—Chest pain—Metformin—polycystic ovary syndrome	0.000439	0.014	CcSEcCtD
Timolol—Myalgia—Metformin—polycystic ovary syndrome	0.000439	0.014	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000436	0.014	CcSEcCtD
Timolol—Discomfort—Metformin—polycystic ovary syndrome	0.000434	0.0139	CcSEcCtD
Timolol—Oedema—Metformin—polycystic ovary syndrome	0.000421	0.0135	CcSEcCtD
Timolol—Infection—Metformin—polycystic ovary syndrome	0.000418	0.0134	CcSEcCtD
Timolol—Shock—Metformin—polycystic ovary syndrome	0.000414	0.0132	CcSEcCtD
Timolol—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000413	0.0132	CcSEcCtD
Timolol—Skin disorder—Metformin—polycystic ovary syndrome	0.000409	0.0131	CcSEcCtD
Timolol—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000407	0.013	CcSEcCtD
Timolol—Anorexia—Metformin—polycystic ovary syndrome	0.000401	0.0128	CcSEcCtD
Timolol—Hypotension—Metformin—polycystic ovary syndrome	0.000393	0.0126	CcSEcCtD
Timolol—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000383	0.0123	CcSEcCtD
Timolol—Paraesthesia—Metformin—polycystic ovary syndrome	0.000378	0.0121	CcSEcCtD
Timolol—Dyspnoea—Metformin—polycystic ovary syndrome	0.000375	0.012	CcSEcCtD
Timolol—Somnolence—Metformin—polycystic ovary syndrome	0.000374	0.012	CcSEcCtD
Timolol—Dyspepsia—Metformin—polycystic ovary syndrome	0.00037	0.0119	CcSEcCtD
Timolol—Decreased appetite—Metformin—polycystic ovary syndrome	0.000366	0.0117	CcSEcCtD
Timolol—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000363	0.0116	CcSEcCtD
Timolol—Fatigue—Metformin—polycystic ovary syndrome	0.000363	0.0116	CcSEcCtD
Timolol—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000347	0.0111	CcSEcCtD
Timolol—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000344	0.011	CcSEcCtD
Timolol—Urticaria—Metformin—polycystic ovary syndrome	0.000334	0.0107	CcSEcCtD
Timolol—Abdominal pain—Metformin—polycystic ovary syndrome	0.000333	0.0106	CcSEcCtD
Timolol—Asthenia—Metformin—polycystic ovary syndrome	0.000302	0.00966	CcSEcCtD
Timolol—Pruritus—Metformin—polycystic ovary syndrome	0.000298	0.00953	CcSEcCtD
Timolol—Diarrhoea—Metformin—polycystic ovary syndrome	0.000288	0.00921	CcSEcCtD
Timolol—Dizziness—Metformin—polycystic ovary syndrome	0.000278	0.00891	CcSEcCtD
Timolol—Vomiting—Metformin—polycystic ovary syndrome	0.000268	0.00856	CcSEcCtD
Timolol—Rash—Metformin—polycystic ovary syndrome	0.000265	0.00849	CcSEcCtD
Timolol—Dermatitis—Metformin—polycystic ovary syndrome	0.000265	0.00848	CcSEcCtD
Timolol—Headache—Metformin—polycystic ovary syndrome	0.000264	0.00844	CcSEcCtD
Timolol—ADRB1—adipose tissue—polycystic ovary syndrome	0.000255	0.0566	CbGeAlD
Timolol—Nausea—Metformin—polycystic ovary syndrome	0.00025	0.008	CcSEcCtD
Timolol—ADRB1—endocrine gland—polycystic ovary syndrome	0.000199	0.044	CbGeAlD
Timolol—CYP2C19—vagina—polycystic ovary syndrome	0.00017	0.0377	CbGeAlD
Timolol—CYP2C19—endocrine gland—polycystic ovary syndrome	0.000159	0.0352	CbGeAlD
Timolol—ABCB1—embryo—polycystic ovary syndrome	0.00013	0.0287	CbGeAlD
Timolol—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000106	0.0236	CbGeAlD
Timolol—CYP2D6—female gonad—polycystic ovary syndrome	9.95e-05	0.022	CbGeAlD
Timolol—ABCB1—endometrium—polycystic ovary syndrome	9.5e-05	0.021	CbGeAlD
Timolol—CYP2D6—endocrine gland—polycystic ovary syndrome	9.25e-05	0.0205	CbGeAlD
Timolol—ABCB1—uterus—polycystic ovary syndrome	8.75e-05	0.0194	CbGeAlD
Timolol—ABCB1—pituitary gland—polycystic ovary syndrome	8.59e-05	0.019	CbGeAlD
Timolol—ABCB1—adipose tissue—polycystic ovary syndrome	8.56e-05	0.019	CbGeAlD
Timolol—ABCB1—adrenal gland—polycystic ovary syndrome	7.68e-05	0.017	CbGeAlD
Timolol—ABCB1—female gonad—polycystic ovary syndrome	7.16e-05	0.0159	CbGeAlD
Timolol—ABCB1—vagina—polycystic ovary syndrome	7.11e-05	0.0158	CbGeAlD
Timolol—ABCB1—endocrine gland—polycystic ovary syndrome	6.66e-05	0.0147	CbGeAlD
Timolol—ADRB2—Signaling Pathways—PTAFR—polycystic ovary syndrome	3.81e-05	0.000319	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	3.79e-05	0.000318	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	3.78e-05	0.000317	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	3.7e-05	0.00031	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	3.7e-05	0.00031	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	3.68e-05	0.000308	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	3.65e-05	0.000306	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—LPCAT2—polycystic ovary syndrome	3.63e-05	0.000304	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—SUOX—polycystic ovary syndrome	3.63e-05	0.000304	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—YAP1—polycystic ovary syndrome	3.63e-05	0.000304	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	3.6e-05	0.000301	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	3.59e-05	0.000301	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—INHBB—polycystic ovary syndrome	3.58e-05	0.0003	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—GAB1—polycystic ovary syndrome	3.58e-05	0.0003	CbGpPWpGaD
Timolol—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	3.55e-05	0.000297	CbGpPWpGaD
Timolol—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	3.55e-05	0.000297	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—INHBB—polycystic ovary syndrome	3.5e-05	0.000294	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—INSR—polycystic ovary syndrome	3.42e-05	0.000287	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ISYNA1—polycystic ovary syndrome	3.38e-05	0.000283	CbGpPWpGaD
Timolol—CYP2C19—Biological oxidations—POMC—polycystic ovary syndrome	3.37e-05	0.000282	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PDE3B—polycystic ovary syndrome	3.34e-05	0.00028	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	3.34e-05	0.00028	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	3.34e-05	0.00028	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	3.3e-05	0.000277	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	3.3e-05	0.000276	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PDE3B—polycystic ovary syndrome	3.27e-05	0.000274	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	3.26e-05	0.000273	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.25e-05	0.000273	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.2e-05	0.000268	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	3.19e-05	0.000267	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PGR—polycystic ovary syndrome	3.17e-05	0.000266	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	3.11e-05	0.00026	CbGpPWpGaD
Timolol—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	3.1e-05	0.000259	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	3.08e-05	0.000258	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—FSHR—polycystic ovary syndrome	3.05e-05	0.000255	CbGpPWpGaD
Timolol—ADRB1—GPCR ligand binding—POMC—polycystic ovary syndrome	2.98e-05	0.00025	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—FSHR—polycystic ovary syndrome	2.98e-05	0.00025	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—GHRL—polycystic ovary syndrome	2.96e-05	0.000248	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—GHRL—polycystic ovary syndrome	2.95e-05	0.000247	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PLAT—polycystic ovary syndrome	2.95e-05	0.000247	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	2.92e-05	0.000245	CbGpPWpGaD
Timolol—ADRB2—GPCR ligand binding—POMC—polycystic ovary syndrome	2.92e-05	0.000244	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	2.91e-05	0.000244	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—GHRL—polycystic ovary syndrome	2.9e-05	0.000243	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—AKR1C2—polycystic ovary syndrome	2.87e-05	0.000241	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—TEAD2—polycystic ovary syndrome	2.87e-05	0.000241	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.86e-05	0.00024	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.84e-05	0.000238	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—ATF1—polycystic ovary syndrome	2.81e-05	0.000236	CbGpPWpGaD
Timolol—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	2.8e-05	0.000235	CbGpPWpGaD
Timolol—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	2.8e-05	0.000235	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.8e-05	0.000235	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.79e-05	0.000233	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	2.76e-05	0.000231	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.74e-05	0.00023	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.73e-05	0.000229	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.72e-05	0.000228	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	2.72e-05	0.000228	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—FST—polycystic ovary syndrome	2.71e-05	0.000227	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.7e-05	0.000226	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.68e-05	0.000225	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—FST—polycystic ovary syndrome	2.66e-05	0.000222	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—LHB—polycystic ovary syndrome	2.65e-05	0.000222	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	2.64e-05	0.000221	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	2.64e-05	0.000221	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.62e-05	0.00022	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—NGFR—polycystic ovary syndrome	2.59e-05	0.000217	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—LHB—polycystic ovary syndrome	2.59e-05	0.000217	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.59e-05	0.000217	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—POMC—polycystic ovary syndrome	2.58e-05	0.000216	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PRL—polycystic ovary syndrome	2.57e-05	0.000215	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	2.54e-05	0.000213	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.53e-05	0.000212	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.51e-05	0.00021	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.5e-05	0.00021	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	2.5e-05	0.000209	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SCT—polycystic ovary syndrome	2.48e-05	0.000208	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.48e-05	0.000208	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.45e-05	0.000206	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.45e-05	0.000205	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.45e-05	0.000205	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.44e-05	0.000204	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SCT—polycystic ovary syndrome	2.43e-05	0.000203	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	2.41e-05	0.000202	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.37e-05	0.000198	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	2.35e-05	0.000197	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—FGF18—polycystic ovary syndrome	2.33e-05	0.000195	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	2.32e-05	0.000195	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.32e-05	0.000194	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—RBP4—polycystic ovary syndrome	2.31e-05	0.000193	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	2.28e-05	0.000191	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—FGF18—polycystic ovary syndrome	2.28e-05	0.000191	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.27e-05	0.00019	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—GNAS—polycystic ovary syndrome	2.26e-05	0.00019	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—RBP4—polycystic ovary syndrome	2.26e-05	0.000189	CbGpPWpGaD
Timolol—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	2.23e-05	0.000187	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.22e-05	0.000186	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	2.21e-05	0.000185	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	2.18e-05	0.000182	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.15e-05	0.000181	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—YAP1—polycystic ovary syndrome	2.15e-05	0.000181	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.15e-05	0.00018	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—GAB1—polycystic ovary syndrome	2.13e-05	0.000178	CbGpPWpGaD
Timolol—ABCB1—Metabolism—STAR—polycystic ovary syndrome	2.12e-05	0.000178	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	2.12e-05	0.000178	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—NRG1—polycystic ovary syndrome	2.12e-05	0.000177	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—YAP1—polycystic ovary syndrome	2.11e-05	0.000177	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	2.1e-05	0.000176	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—GAB1—polycystic ovary syndrome	2.08e-05	0.000174	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—INSR—polycystic ovary syndrome	2.03e-05	0.00017	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	2e-05	0.000168	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—INSR—polycystic ovary syndrome	1.99e-05	0.000167	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	1.94e-05	0.000163	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.93e-05	0.000162	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.9e-05	0.000159	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	1.9e-05	0.000159	CbGpPWpGaD
Timolol—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	1.89e-05	0.000159	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.89e-05	0.000158	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PGR—polycystic ovary syndrome	1.88e-05	0.000158	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.86e-05	0.000156	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	1.85e-05	0.000155	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PGR—polycystic ovary syndrome	1.84e-05	0.000154	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.83e-05	0.000153	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IRS2—polycystic ovary syndrome	1.81e-05	0.000152	CbGpPWpGaD
Timolol—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	1.81e-05	0.000151	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	1.78e-05	0.00015	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.78e-05	0.000149	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—LEP—polycystic ovary syndrome	1.77e-05	0.000149	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—GHRL—polycystic ovary syndrome	1.75e-05	0.000147	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PLAT—polycystic ovary syndrome	1.75e-05	0.000147	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.73e-05	0.000145	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—GHRL—polycystic ovary syndrome	1.71e-05	0.000143	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PLAT—polycystic ovary syndrome	1.71e-05	0.000143	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	1.7e-05	0.000143	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	1.69e-05	0.000141	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.69e-05	0.000141	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ATF1—polycystic ovary syndrome	1.67e-05	0.00014	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	1.65e-05	0.000138	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.65e-05	0.000138	CbGpPWpGaD
Timolol—ABCB1—Metabolism—LHB—polycystic ovary syndrome	1.65e-05	0.000138	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ATF1—polycystic ovary syndrome	1.63e-05	0.000137	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.63e-05	0.000136	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.62e-05	0.000136	CbGpPWpGaD
Timolol—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	1.61e-05	0.000135	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	1.6e-05	0.000134	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.59e-05	0.000133	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.58e-05	0.000133	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IRS1—polycystic ovary syndrome	1.58e-05	0.000133	CbGpPWpGaD
Timolol—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	1.56e-05	0.000131	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	1.55e-05	0.00013	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NGFR—polycystic ovary syndrome	1.54e-05	0.000129	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—POMC—polycystic ovary syndrome	1.53e-05	0.000128	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PRL—polycystic ovary syndrome	1.53e-05	0.000128	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—POMC—polycystic ovary syndrome	1.52e-05	0.000128	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	1.52e-05	0.000127	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—INS—polycystic ovary syndrome	1.51e-05	0.000127	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NGFR—polycystic ovary syndrome	1.51e-05	0.000126	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—POMC—polycystic ovary syndrome	1.5e-05	0.000125	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PRL—polycystic ovary syndrome	1.49e-05	0.000125	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.47e-05	0.000123	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	1.47e-05	0.000123	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	1.47e-05	0.000123	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IGF1—polycystic ovary syndrome	1.47e-05	0.000123	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—AKT2—polycystic ovary syndrome	1.46e-05	0.000123	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.45e-05	0.000121	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.44e-05	0.000121	CbGpPWpGaD
Timolol—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	1.44e-05	0.00012	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	1.42e-05	0.000119	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.39e-05	0.000117	CbGpPWpGaD
Timolol—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	1.39e-05	0.000116	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	1.37e-05	0.000115	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	1.35e-05	0.000113	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—GNAS—polycystic ovary syndrome	1.34e-05	0.000112	CbGpPWpGaD
Timolol—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	1.34e-05	0.000112	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	1.32e-05	0.00011	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—GNAS—polycystic ovary syndrome	1.31e-05	0.00011	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.31e-05	0.00011	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	1.31e-05	0.00011	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	1.3e-05	0.000109	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.29e-05	0.000108	CbGpPWpGaD
Timolol—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	1.29e-05	0.000108	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.28e-05	0.000107	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	1.27e-05	0.000107	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	1.26e-05	0.000106	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NRG1—polycystic ovary syndrome	1.26e-05	0.000105	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.25e-05	0.000105	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	1.23e-05	0.000103	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NRG1—polycystic ovary syndrome	1.23e-05	0.000103	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	1.21e-05	0.000102	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	1.21e-05	0.000101	CbGpPWpGaD
Timolol—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	1.2e-05	0.000101	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	1.2e-05	0.0001	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	1.18e-05	9.9e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	1.13e-05	9.48e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—IL6—polycystic ovary syndrome	1.12e-05	9.39e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	1.11e-05	9.33e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IRS2—polycystic ovary syndrome	1.08e-05	9.01e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—LEP—polycystic ovary syndrome	1.05e-05	8.82e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IRS2—polycystic ovary syndrome	1.05e-05	8.81e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—TH—polycystic ovary syndrome	1.05e-05	8.78e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—LEP—polycystic ovary syndrome	1.03e-05	8.63e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—TH—polycystic ovary syndrome	1.02e-05	8.57e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	1.02e-05	8.54e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	9.95e-06	8.33e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—TH—polycystic ovary syndrome	9.64e-06	8.07e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	9.58e-06	8.03e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—VEGFA—polycystic ovary syndrome	9.57e-06	8.02e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IRS1—polycystic ovary syndrome	9.39e-06	7.87e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	9.37e-06	7.85e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	9.35e-06	7.84e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IRS1—polycystic ovary syndrome	9.18e-06	7.69e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—POMC—polycystic ovary syndrome	9.04e-06	7.57e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—INS—polycystic ovary syndrome	8.99e-06	7.53e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—POMC—polycystic ovary syndrome	8.84e-06	7.41e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	8.81e-06	7.38e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—INS—polycystic ovary syndrome	8.79e-06	7.37e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IGF1—polycystic ovary syndrome	8.7e-06	7.29e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—AKT2—polycystic ovary syndrome	8.69e-06	7.28e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	8.55e-06	7.17e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IGF1—polycystic ovary syndrome	8.51e-06	7.13e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—AKT2—polycystic ovary syndrome	8.5e-06	7.12e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	8.35e-06	6.99e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.26e-06	6.92e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	8.15e-06	6.83e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.08e-06	6.77e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	7.95e-06	6.66e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	7.87e-06	6.59e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	7.72e-06	6.47e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	7.54e-06	6.32e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	7.49e-06	6.28e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	7.2e-06	6.03e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	7.1e-06	5.95e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	7.03e-06	5.89e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—IL6—polycystic ovary syndrome	6.65e-06	5.57e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	6.62e-06	5.55e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IL6—polycystic ovary syndrome	6.62e-06	5.55e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—IL6—polycystic ovary syndrome	6.51e-06	5.45e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	5.84e-06	4.89e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	5.76e-06	4.82e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—INS—polycystic ovary syndrome	5.73e-06	4.8e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	5.7e-06	4.77e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.68e-06	4.76e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—POMC—polycystic ovary syndrome	5.62e-06	4.71e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—INS—polycystic ovary syndrome	5.59e-06	4.68e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.56e-06	4.66e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	5.37e-06	4.5e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	5.3e-06	4.44e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—INS—polycystic ovary syndrome	5.27e-06	4.41e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IL6—polycystic ovary syndrome	3.93e-06	3.29e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IL6—polycystic ovary syndrome	3.84e-06	3.22e-05	CbGpPWpGaD
